Bayer today showcased significant advancements in its pharmaceutical growth strategy and pipeline at its recent annual Pharma ...

The FDA converts its accelerated approval to full approval for BAYRY's oncology drug, Vitrakvi, on positive data from ...

European pharma companies warned the European Commission president at a meeting on Tuesday that U.S. tariffs would expedite ...

Talking about the importance of science in agriculture, Emma Manolache, Public Affairs Lead for Romania, Bulgaria and ...

The EU executive and top pharmaceutical companies shared a video call to address concerns over potential US tariffs on drugs ...

Recursion Pharmaceuticals, Inc.’s RXRX share price has surged by 17.29%, which has investors questioning if this is right ...

and the Bayer Cross was used as the trademark for all of the I.G.'s pharmaceutical products. In the early 1930s, the Wupperal-Elberfeld facility continued its successful research into drugs to ...

Tánaiste Simon Harris has said any future tariff negotiations between the EU and the US should include the pharmaceutical ...

Bayer seeks EMA approval for aflibercept 8 mg for treatment of retinal vein occlusion: Berlin Thursday, April 10, 2025, 16:00 Hrs [IST] Bayer has submitted an application to the E ...

However, Bayer's top-selling pharma product Xarelto (rivaroxaban), an anticoagulant, continued to succumb to generic competition with a near-11% fall to €904 million. The solid quarter is ...